| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

Christian H. Eggers,1
Juan C. Salazar,3 and
Justin D. Radolf1,2*
Departments of Medicine,1 Genetics and Developmental Biology, University of Connecticut Health Center, Farmington, Connecticut 06030-3715,2 Division of Pediatric Infectious Diseases, Department of Pediatrics, Connecticut Children's Medical Center, Hartford, Connecticut 061063
Received 18 October 2006/ Returned for modification 17 November 2006/ Accepted 2 January 2007
| ABSTRACT |
|---|
|
|
|---|
) from NK cells. B. burgdorferi was phagocytosed avidly by monocytes, while T. pallidum was not, suggesting that the enhanced response to live B. burgdorferi was due to phagocytosis of the organism. When cytochalasin D was used to block phagocytosis of live B. burgdorferi, cytokine production decreased to levels comparable to those induced by B. burgdorferi lysates, while the IFN-
response was abrogated altogether. In the presence of human syphilitic serum, T. pallidum was efficiently internalized and initiated responses resembling those observed with live B. burgdorferi, including the production of IFN-
by NK cells. Depletion of monocytes revealed that they were the primary source of inflammatory cytokines, while dendritic cells (DCs) directed IFN-
production from innate lymphocytes. Thus, phagocytosis of live spirochetes initiates cell activation programs in monocytes and DCs that differ qualitatively and quantitatively from those induced at the cell surface by lipoprotein-enriched lysates. The greater stimulatory capacity of B. burgdorferi versus T. pallidum appears to be explained by the successful recognition and phagocytosis of B. burgdorferi by host cells and the ability of T. pallidum to avoid detection and uptake by virtue of its denuded outer membrane rather than by differences in surface lipoprotein expression. | INTRODUCTION |
|---|
|
|
|---|
Genomic analysis of B. burgdorferi and T. pallidum has revealed that these pathogens lack orthologs of known exotoxins as well as the specialized secretory machinery required for the delivery of noxious molecules into host cells (14, 25, 26). Therefore, it is now generally accepted that the morbidity and mortality associated with syphilis and Lyme disease are a direct consequence of the inflammatory responses elicited by their etiologic agents (63, 81). B. burgdorferi and T. pallidum lack the classical gram-negative constituent lipopolysaccharide (LPS), which typically stimulates immune cells by Toll-like receptor 4 (TLR4) (2). Instead, they express numerous bacterial lipoproteins (BLPs) (14, 25, 26), which activate innate immune cells via TLR2/1 heterodimers in a CD14-dependent manner (2-4, 11, 35, 70, 80). Intradermal injection of synthetic lipoprotein analogs (lipopeptides) in both animals and humans has confirmed that these molecules can exert proinflammatory activities in vivo and that they have the capacity to recruit diverse leukocyte subsets into tissues (67, 71). In addition to initiating the innate immune response, TLR-derived signals also are essential in directing adaptive immune responses. Engagement of TLR2 by lipoproteins induces dendritic cell (DC) maturation whereby antigen processing is enhanced and major histocompatibility complex and costimulatory molecules are upregulated (10). Activation of DCs via TLR2 also has been shown to be critical for Th1 polarization during the priming of naïve T cells (72).
TLR-ligand interactions originally were studied as cell surface phenomena (18); it is now well documented, however, that some pathogen-associated molecular patterns (PAMPs), such as prokaryotic DNA, engage their cognate TLRs only from within intracellular compartments (1, 41). In addition, receptors such as TLR1, TLR2, and TLR6 that act at the cell surface also can be recruited to phagolysosomes, where they sample vacuolar contents (61, 77). Several years ago, we reported that live T. pallidum is markedly less stimulatory for THP-1 monocytic cells than live B. burgdorferi (69). We attributed this difference to the fact that B. burgdorferi surface lipoproteins are directly accessible to TLRs on monocytes, while cellular activation by T. pallidum, which has no demonstrated surface-exposed lipoproteins (13, 64), likely requires the liberation of sequestered PAMPs following degradation of the organisms within phagolysosomes (69). In this study, we sought to clarify the relative importance of cell surface versus intracellular activation by spirochetal pathogens. Contrary to results obtained using THP-1 cells, we found by using an ex vivo peripheral blood mononuclear cell (PBMC) model that live B. burgdorferi induced a response that differed quantitatively and qualitatively from that of B. burgdorferi lysates and that this augmented response was dependent on phagocytosis of the spirochetes. While B. burgdorferi demonstrated greater stimulatory capacity than unopsonized T. pallidum, this difference was essentially negated when opsonic antibody in human syphilitic serum was employed to drive uptake of treponemes into phagosomes. We also found that phagocytosis of spirochetes not only generated distinctive monocyte responses but also induced DCs to stimulate gamma interferon (IFN-
) production by innate lymphocytes, potentially setting the stage for the intense Th1 polarization seen in both syphilis and Lyme disease (68, 78). Thus, the greater stimulatory capacity of B. burgdorferi versus T. pallidum appears to be explained by the successful recognition and phagocytosis of B. burgdorferi by host cells and the ability of T. pallidum to avoid detection and uptake by virtue of its denuded outer membrane rather than by differences in surface lipoprotein expression.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Bacterial strains. Low-passage B. burgdorferi 297 was propagated in Barbour-Stoenner-Kelly medium containing 6% rabbit serum (Sigma). Spirochetes grown at 23°C were temperature shifted to 37°C; organisms were harvested at mid-log to late log phase (4 to 8 x 107/ml) by centrifugation at 8,000 x g, washed twice in CMRL (Gibco), and resuspended in RPMI medium (Gibco). For the microscopy studies, virulent B. burgdorferi 297 engineered to express green fluorescent protein (GFP) under the direction of the constitutive flaB promoter (20, 21) was prepared as described above. T. pallidum subsp. pallidum (Nichols strain) was propagated by intratesticular inoculation of adult New Zealand White rabbits as previously described (32) in strict accordance with a protocol approved by the UCHC Animal Care Committee. Treponemes were extracted from rabbit testes in CMRL, pelleted once by centrifugation at 14,000 x g, resuspended in RPMI, and enumerated by dark-field microscopy on a Petroff-Hausser counting chamber (Hausser Scientific).
Reagents. A synthetic bacterial lipohexapeptide (BLP) corresponding to the N terminus of Escherichia coli murine lipoprotein (Bachem Bioscience) was used at a concentration of 10 µg/ml. LPS Re595 (Sigma) was suspended at 5 mg/ml in 0.2% triethylamine, repurified as previously described (36), and used at a final concentration of 100 ng/ml. B. burgdorferi and T. pallidum lysates were prepared from live organisms by sonication. The equivalence of live and lysed spirochete preparations was confirmed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and silver staining.
Cell preparation and stimulation. THP-1 cells were propagated in RPMI supplemented with 10% fetal bovine serum (FBS) to a density of 1 x 106/ml and then matured with 160 ng/ml vitamin D3 (Biomol) for 72 to 96 h. The matured cells were washed in Hanks balanced salt solution (HBSS), plated at 1 x 106/ml in 24-well tissue culture plates, and stimulated with live or lysed spirochetes at multiplicities of infection (MOIs) of 1, 10, and 100 or with LPS (100 ng/ml) or BLP (10 µg/ml). Cells were incubated for 6 h prior to collection of supernatants for cytokine analysis. For phagocytosis studies, 1-µm Fluoresbrite carboxylated polystyrene microspheres (Polysciences, Inc.) were used as controls. Bead dilutions were prepared to mimic the spirochete MOIs.
Human PBMCs were isolated by Ficoll density gradient centrifugation according to the instructions of the manufacturer (Amersham Biosciences). Cells were washed three times with HBSS, counted on a hemocytometer, and resuspended at 1 x 106/ml in RPMI-10% FBS. Cells were plated and stimulated with live or lysed spirochetes or control agonists as described above and incubated for 8 h at 37°C with 5% CO2 prior to analysis. Selected samples were incubated with 10 µM cytochalasin D (CytoD) (Sigma) or LysoTracker Red endosomal dye (Molecular Probes). Some experiments with live T. pallidum included samples containing 10% heat-inactivated (56°C for 30 min) pooled human syphilitic serum (HSS) or normal human serum (NHS). When intracellular staining was performed, brefeldin A (Golgiplug; BD) was added at 4 h into the incubation at a dilution of 1 µl/ml. As a control for the effects of opsonic antibody, beads were incubated with 400 µg/ml of purified human immunoglobulin G (IgG) (Sigma) for 1 h at 37°C and then washed twice to remove unbound antibody. Antibody coating was confirmed by counterstaining with anti-human IgG-allophycocyanin (APC) antibody (BD). Microscopy experiments were performed on PBMCs incubated with spirochetes or beads for 4 h. LPS levels in culture media and reagents were confirmed by Limulus assay (Cambrex) to be <10 pg/ml.
Cell Staining and flow cytometry.
All antibody conjugates were purchased from either BD Pharmingen or eBioscience. The antibody panels used in the four-parameter staining of PBMCs are listed in Table 1. Unstimulated or stimulated PBMCs were harvested from tissue culture plates and washed once in fluorescence-activated cell sorting (FACS) buffer (phosphate-buffered saline, 0.1% bovine serum albumin, 0.055% Na azide) in preparation for flow cytometry. Cells were incubated for 10 min at 4°C with 10 µg of purified human IgG (Sigma) for Fc receptor (FcR) blocking, followed by a 20-min incubation with fluorochrome-conjugated antibodies. After a final wash in FACS buffer, cells were fixed in FACS buffer plus 6.25% paraformaldehyde. Individual cell populations were selectively gated for analysis based on the following expression phenotypes: monocytes, CD14+; monocytoid DCs (mDCs), lineage HLA-DR+ CD11c+; plasmacytoid DCs (pDCs), lineage HLA-DR+ CD11c; NK cells, = CD56 or CD57+ CD3; NKT cells, CD56 or CD57+ CD3+; 
T cells, 
T-cell receptor+ CD3+.
|
-APC antibody and incubated for 30 min at 4°C. After two washes in PermWash, the cells were resuspended in FACS buffer and analyzed immediately. Flow cytometry was performed using a FACSCalibur dual-laser flow cytometer (BD); a minimum of 100,000 events and a maximum of 500,000 events were collected, depending on the cell type of interest. Multiparameter files were analyzed using WinMDI v2.8 software (Joseph Trotter, Scripps Clinic).
Cytokine analysis.
Simultaneous measurements of IFN-
, tumor necrosis factor alpha (TNF-
), and interleukin-6 (IL-6) were performed using the human Th1/Th2 Cytokine Bead Array (BD) per the manufacturer's protocol. Alternatively, the human inflammatory Cytokine Bead Array kit was used to measure TNF-
, IL-6, IL-1ß, and IL-12p70. IL-12p70 also was measured by ultrasensitive enzyme-linked immunosorbent assay (Biosource).
Microscopy. Following a 4-h incubation with GFP-expressing B. burgdorferi (B. burgdorferi-GFP), cells were harvested, mounted onto a microscope slide, and viewed immediately on an Olympus Bx60 mercury arc lamp fluorescence microscope at x400 or x1,000 under oil immersion. Incorporation of GFP fluorescence was visualized using a 470- to 490-nm excitation filter cube (Olympus). T. pallidum-cell associations were visualized by immunofluorescence assay (IFA) as described by Lukehart and Miller (45). HSS pooled from five secondary syphilis patients was diluted 1:100 in CMRL-10% goat serum and used as the primary antibody. NHS was used as an assay control. Secondary goat anti-human IgG antibody conjugated to fluorescein isothiocyanate (FITC) (Zymed) was used at a dilution of 1:250. Cells were visualized as described above for B. burgdorferi-GFP.
Depletion of monocytes from PBMCs by magnetic cell sorting. PBMCs were suspended in ice-cold sorting buffer (phosphate-buffered saline, 2 mM EDTA, 0.5% bovine serum albumin, pH 7.2) and incubated with metallic bead-conjugated antibodies specific for CD14 or CD56 for the collection of monocytes or NK cells, respectively. Cells were then passed twice through separate ferromagnetic columns held in a magnetic field. The flowthrough was collected as the "depleted" cell fraction; the retained cells were harvested by flushing the column outside of the magnetic field. Sorted cells were washed twice with HBSS and resuspended in RPMI-10% FBS. The sorting magnet, separation columns, and all antibody conjugates were purchased from Miltenyi Biotech.
Statistical analysis.
Statistical analysis was performed using Microsoft Excel software. For comparison of each parameter, paired or unpaired Student t tests were performed, depending on whether the values were generated from within the same experiments or from parallel studies. All tests were two tailed and specified to a 95% confidence interval. For each value, both the standard deviation and the standard error about the mean were calculated. P values of
0.05 were considered significant.
| RESULTS |
|---|
|
|
|---|
response, which was evident at the lowest MOI examined (1:1) and which was similar to the responses elicited by corresponding lysates. In contrast, live T. pallidum proved to be a much poorer activator of these cells in comparison to the equivalent doses of treponemal lysates; an appreciable response to live T. pallidum was evident only at an MOI of 100:1. To determine whether live spirochetes were taken up by the THP-1 cells, we used B. burgdorferi-GFP and IFA for T. pallidum. Although occasional binding of spirochetes to the cells was apparent, neither B. burgdorferi nor T. pallidum appeared to be internalized by this cell line (Fig. 1B). Thus, activation of these cells by spirochetes appears to occur predominantly or exclusively at the cell surface, while the difference in potency between the two spirochetal pathogens presumably is due to the presence of abundant lipoproteins on the surface of B. burgdorferi and the paucity of these and other PAMPs on the surface of T. pallidum (13, 64). As a test of general phagocytic capacity, we incubated cells with fluorescent polystyrene beads and found that our cell line was indeed capable of phagocytosis (Fig. 1B).
|
and IL-1ß (Fig. 2B), as well as of IL-6 (data not shown). The results for IFN-
were particularly striking; although the relative amounts of this cytokine in culture supernatants varied widely between different cell donors, it was consistently and reproducibly detected only in response to live B. burgdorferi (Fig. 3A). ICS revealed that NK cells were the primary producers of IFN-
in response to B. burgdorferi (Fig. 3B); also evident is the high degree of sensitivity of ICS for detecting production of IFN-
in minor lymphocyte populations. In contrast to live B. burgdorferi, which elicited a strong inflammatory response even at a spirochete-to-cell ratio of 1:1, monocyte activation and cytokine production in response to live T. pallidum were significantly above background only at MOIs of 10:1 or greater. Furthermore, compared to B. burgdorferi, live T. pallidum induced significantly less surface expression of CD40 and CD83 by monocytes (Fig. 4A), decreased production of TNF-
and IL-1ß (Fig. 4B) and IL-6 (data not shown), and no IFN-
(see Fig. 6D, left panels). Duplicate head-to-head comparisons of B. burgdorferi and T. pallidum confirmed that the difference in potency between the live organisms was not due to experiment-to-experiment variation (not shown).
|
|
|
|
response was abrogated altogether (Fig. 5C). Flow cytometry confirmed that CytoD at the dosage used (10 µg/ml) virtually eliminated the uptake of B. burgdorferi-GFP by monocytes at an MOI of 10:1 and markedly inhibited uptake of spirochetes at the highest MOI (100:1) employed. (Fig. 5D).
|
|
(Fig. 6C), IL-6 (not shown), and IL-1ß (not shown). The de novo induction of IFN-
by opsonized T. pallidum (Fig. 6C and D) further differentiated this response from that induced by unopsonized treponemes. The IFN-
response to low MOIs of T. pallidum resembled that induced by B. burgdorferi in that it was mediated primarily by NK cells (compare Fig. 6D with 3D). High concentrations of opsonized T. pallidum, however, induced the production of this cytokine from a broader spectrum of innate lymphocytes, namely, NK cells, NKT cells, and 
T cells (Fig. 6D). A small number of CD3+ CD8+ cells, likely representing CD8+ 
and/or NKT cells (or iNKT cells) (37, 40), also produced IFN-
in response to high levels of opsonized T. pallidum (Fig. 6D, bottom row). To confirm that the responses observed were due to uptake and degradation of T. pallidum and not FcR signaling, we incubated PBMCs with carboxylate beads coated with human IgG; opsonized beads were highly internalized but did not induce cytokines (Fig. 7).
|
production in response to live spirochetes, we depleted the CD14+ cells from the mixture via magnetic cell sorting, typically achieving an absorption efficiency of
99%. Monocyte-depleted PBMCs stimulated with live B. burgdorferi (Fig. 8A) or opsonized T. pallidum (Fig. 8B) produced dramatically less TNF-
, IL-1ß, and IL-6 (not shown) than whole PBMCs, demonstrating conclusively that monocytes were the primary source of these proinflammatory cytokines. In contrast, the IFN-
response elicited by B. burgdorferi and T. pallidum (Fig. 8A and B) was unchanged by the depletion of monocytes from PBMCs, indicating that DCs stimulated production of this cytokine from innate lymphocytes. This conclusion was buttressed by the observation that purified NK cells, incubated alone or in coculture with purified monocytes, did not produce IFN-
in response to live B. burgdorferi (data not shown). Interestingly, using ultrasensitive cytokine assays, we were unable to detect IL-12p70, a cytokine known to stimulate NK and 
T cells (9, 51), even in response to high MOIs of B. burgdorferi or opsonized T. pallidum (data not shown).
|
|
| DISCUSSION |
|---|
|
|
|---|
Amplification of the proinflammatory cytokine response to spirochetes from within the phagosome may occur by a number of nonexclusive mechanisms. TLR responses initiated from within the phagosome may be augmented by a high concentration of PAMPs within a relatively small space. In addition, TLR2 and its cooperative pairing partners TLR1 and TLR6 have been shown to be actively recruited to the phagosome (61, 77), and this may lead to a greater receptor density in this compartment than at the cell surface. Phagolysosomes are dynamic organelles that mature, transmit signals to the cytosol, and direct their own interactions with other cellular compartments via a complex set of membranous proteins on the organelle surface (76). Thus, the presence of specific "docking" molecules may provide a particularly effective scaffold for TLR machinery. Yet another possibility is that TLR signaling pathways distinct from those at the cell surface are activated within the phagosome upon the liberation of sequestered PAMPs by bacterial disruption. The fact that some TLRs, such as TLR9, signal only from within phagolysosomes supports this conjecture (1, 41). Several spirochetal constituents, such as flagellin, DNA, and lipoproteins in the case of T. pallidum, would be available to cognate pattern recognition receptors only following spirochetal degradation. The activation of multiple TLRs may then lead to synergistic amplification of the signaling cascade, resulting in greater cytokine secretion. The phenomenon of TLR cooperation to generate immune responses is becoming increasingly recognized (5, 59).
A particularly intriguing finding was the marked amplification of IL-1ß production in response to internalized spirochetes. Unlike the case for other proinflammatory cytokines, which are linearly induced by TLR signaling, the production of biologically active IL-1ß requires the integration of at least two signaling events: NF-
B-mediated induction of pro-IL-1ß synthesis and conversion of the procytokine into its active form by caspase-1 (16, 19). Interestingly, while TLRs are potent inducers of pro-IL-1ß, they are inefficient at initiating caspase-1 activity, which requires the assembly and activation of the cytosolic multimolecular complex known as the inflammasome (50). Therefore, pure PAMPs acting at the cell surface, such as LPS and BLPs, elicit only low levels of active IL-1ß, as demonstrated here (Fig. 2 and 4) and elsewhere (62, 82). We envision two potential mechanisms by which internalized spirochetes activate cytosolic signaling cascades resulting in robust IL-1ß production. First, signals may be transmitted into the cytosol by receptors that traverse the phagosomal membrane. Such intercompartmental signaling may be mediated by TLRs or by as-yet-unidentified phagosomal receptors that may be recruited to the phagosome and activated by spirochetal PAMPs to direct inflammasome assembly. Second, as recently proposed (76), it is possible that the phagosome leaks pathogen components into the cytosol for delivery to cytosolic receptors in a manner analogous to the transfer of antigen for cross-presentation. It is interesting to note that in other models of monocyte-pathogen interactions, activation of caspase-1 is achieved by viable microorganisms due to their ability to escape endosomal compartments and enter the cytoplasm (28, 34) or to secrete material directly into the cytosol via dedicated secretory systems (24, 53, 79). Live spirochetes possess neither of these capabilities.
One of our most striking observations was that IFN-
was produced by innate lymphocytes in an accessory cell-dependent manner exclusively in response to internalized spirochetes. Moreover, in contrast to production of the proinflammatory cytokines, which virtually disappeared when monocytes were removed from the system, IFN-
production was refractory to monocyte depletion. This observation led us to conclude that the activation of innate lymphocytes was mediated by DCs. Both DC subsets internalized spirochetes and were activated to a greater degree by live organisms; several observations, however, suggest that mDCs direct this response. For one, mDCs internalized B. burgdorferi-GFP with greater efficiency than pDCs, consistent with the current paradigm that these cells are more phagocytic and function as the primary antigen-processing and -presenting cells for the initiation of adaptive responses (7, 17). Second, mDCs were highly activated in a direct manner by live spirochetes. In contrast, the strong pDC response to live spirochetes was diminished by the depletion of monocytes, while the IFN-
response remained unchanged, demonstrating a discordance between pDC activation and IFN-
induction in our ex vivo system. Finally, mDCs are well known to activate NK, NKT, and 
T cells by a wide variety of mechanisms (27, 29, 40, 57, 58). Nonetheless, pDCs have been shown to activate NK cells (65) and therefore have not been ruled out as a stimulator of IFN-
production in our ex vivo system. Furthermore, pDC activation in response to B. burgdorferi and T. pallidum is reported to occur in vivo (68, 68a).
The clinical responses observed in both syphilis and Lyme disease are intensely Th1 polarized (68, 78). IFN-
produced by DC-activated NK (and other) cells has been shown to provide a reciprocal signal to DCs for the induction of IL-12, ultimately generating a cytokine milieu that promotes Th1 development in T cells as they are primed in the lymph nodes (46, 49, 74). Thus, the production of IFN-
by innate lymphocytes, as observed in our study, could provide the Th1 priming signal during spirochetal infection. As IFN-
was elicited only by live organisms, and not by lysates or individual PAMPs, the induction of this cytokine in innate lymphocytes could act as a gauge at the innate-adaptive interface for the immune system to differentiate between the presence of proinflammatory agonists and viable pathogens. There is considerable debate about the benefit of a Th1 response in the case of Lyme disease. Th1 responses are classically believed to target intracellular pathogens by providing a signal for enhanced bactericidal killing by macrophages in the form of IFN-
. As B. burgdorferi is an extracellular pathogen that is easily killed by monocytes, as shown here, and by macrophages in the absence of IFN-
(55), the advantage of a Th1 response in the case of B. burgdorferi infection is unclear. Studies with the murine model have demonstrated no requirement for IFN-
in bacterial clearance or disease susceptibility (12, 30) but have suggested that the Th1 response is actually deleterious in the course of Lyme disease (52). On the other hand, a study that carefully examined the kinetics of Th cell polarization in Lyme arthritis-susceptible and -resistant mice demonstrated that the Th1 response in fact correlated with better control of infection early in disease and was detrimental only when prolonged (39). IFN-
has been shown to enhance monocyte effector functions in response to spirochetal constituents (47) and so may function to expedite the recruitment of key immune cells to the site of infection during the initial phases of the disease. In contrast to the case for Lyme disease, the requirement for opsonic antibody helps to explain the benefit of a Th1 response in syphilis. The IgG isotypes generated in a Th1 context, such as IgG2a (75), are bound with a high affinity by activating Fc receptors (Fc
RI and Fc
RIIIa) but poorly by the inhibitory Fc
RIIb (22, 60). Furthermore, IFN-
promotes the process of opsonophagocytosis via the upregulation of activating Fc
Rs and the downregulation of the inhibitory Fc
Rs on monocytes (42).
The work presented here has helped to clarify the mechanisms by which B. burgdorferi and T. pallidum initiate innate and adaptive immune responses. Taken collectively, our data demonstrate that the difference in immunostimulatory capacity between B. burgdorferi and T. pallidum is a result of dramatically different levels of phagocytosis of these two organisms, not the relative abundance of surface-expressed lipoproteins per se as we previously proposed (69). Presumably, live B. burgdorferi displays at least one moiety on its surface, which T. pallidum lacks, that promotes recognition and phagocytosis by host cells. When the host counters this immune evasion strategy via the production of opsonic antibody, the efficiency of T. pallidum internalization is dramatically enhanced, leading to cellular and cytokine responses similar to those generated by B. burgdorferi. FcRs are known to initiate numerous signaling pathways and are reported to downregulate immune responses (31). Our data indicate, however, that the primary purpose of FcRs is to deliver T. pallidum to phagolysosomes for PAMP-mediated recognition, rather than to modulate the pathogen-specific immune response. The delayed onset of constitutional symptoms in syphilis, compared to Lyme disease, may reflect the fact that phagocytosis of T. pallidum and the subsequent generation of inflammatory responses do not occur efficiently until opsonic antibody is generated as part of the adaptive immune response. The intrinsic ability of T. pallidum to evade phagocytosis highlights how exquisitely adapted it is as a human pathogen.
| ACKNOWLEDGMENTS |
|---|
This work was supported by Public Health Service grants AI-26756, AI-29735, and AI-38894 to J.D.R. and by General Clinical Research Center grant M01RR06192 from the National Institutes of Health.
| FOOTNOTES |
|---|
Published ahead of print on 12 January 2007. ![]()
Present address: Department of Immunology, Rush Medical Center, Chicago, IL 60612. ![]()
| REFERENCES |
|---|
|
|
|---|
| 1. | Ahmad-Nejad, P., H. Hacker, M. Rutz, S. Bauer, R. M. Vabulas, and H. Wagner. 2002. Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments. Eur. J. Immunol. 32:1958-1968.[CrossRef][Medline] |
| 2. | Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124:783-801.[CrossRef][Medline] |
| 3. | Alexopoulou, L., V. Thomas, M. Schnare, Y. Lobet, J. Anguita, R. T. Schoen, R. Medzhitov, E. Fikrig, and R. A. Flavell. 2002. Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice. Nat. Med. 8:878-884.[Medline] |
| 4. | Aliprantis, A. O., R. B. Yang, M. R. Mark, S. Suggett, B. Devaux, J. D. Radolf, G. R. Klimpel, P. Godowski, and A. Zychlinsky. 1999. Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2. Science 285:736-739. |
| 5. | Bafica, A., C. A. Scanga, C. G. Feng, C. Leifer, A. Cheever, and A. Sher. 2005. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. J. Exp. Med. 202:1715-1724. |
| 6. | Baker-Zander, S. A., J. M. Shaffer, and S. A. Lukehart. 1993. Characterization of the serum requirement for macrophage-mediated killing of Treponema pallidum ssp. pallidum: relationship to the development of opsonizing antibodies. FEMS Immunol. Med. Microbiol. 6:273-279.[CrossRef][Medline] |
| 7. | Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767-811.[CrossRef][Medline] |
| 8. | Benach, J. L., H. B. Fleit, G. S. Habicht, J. L. Coleman, E. M. Bosler, and B. P. Lane. 1984. Interactions of phagocytes with the Lyme disease spirochete: role of the Fc receptor. J. Infect. Dis. 150:497-507.[Medline] |
| 9. | Biron, C. A., K. B. Nguyen, G. C. Pien, L. P. Cousens, and T. P. Salazar- Mather. 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17:189-220.[CrossRef][Medline] |
| 10. | Blander, J. M., and R. Medzhitov. 2006. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 440:808-812.[CrossRef][Medline] |
| 11. | Brightbill, H. D., D. H. Libraty, S. R. Krutzik, R. B. Yang, J. T. Belisle, J. R. Bleharski, M. Maitland, M. V. Norgard, S. E. Plevy, S. T. Smale, P. J. Brennan, B. R. Bloom, P. J. Godowski, and R. L. Modlin. 1999. Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors. Science 285:732-736. |
| 12. | Brown, C. R., and S. L. Reiner. 1999. Experimental Lyme arthritis in the absence of interleukin-4 or gamma interferon. Infect. Immun. 67:3329-3333. |
| 13. | Cameron, C. E. 2006. The T. pallidum outer membrane and outer membrane proteins, p. 237-266. In J. D. Radolf and S. A. Lukehart (ed.), Pathogenic treponemes: molecular and cellular biology. Caister Academic Press, Norwich, United Kingdom. |
| 14. | Casjens, S., N. Palmer, R. van Vugt, W. M. Huang, B. Stevenson, P. Rosa, R. Lathigra, G. Sutton, J. Peterson, R. J. Dodson, D. Haft, E. Hickey, M. Gwinn, O. White, and C. M. Fraser. 2000. A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi. Mol. Microbiol. 35:490-516.[CrossRef][Medline] |
| 15. | Chiani, P., C. Bromuro, and A. Torosantucci. 2000. Defective induction of interleukin-12 in human monocytes by germ-tube forms of Candida albicans. Infect. Immun. 68:5628-5634. |
| 16. | Cogswell, J. P., M. M. Godlevski, G. B. Wisely, W. C. Clay, L. M. Leesnitzer, J. P. Ways, and J. G. Gray. 1994. NF- B regulates IL-1B transcription through a consensus NF- B binding site and a nonconsensus CRE-like site. J. Immunol. 153:712-723.[Abstract] |
| 17. | Colonna, M., G. Trinchieri, and Y. J. Liu. 2004. Plasmacytoid dendritic cells in immunity. Nat. Immunol. 5:1219-1226.[CrossRef][Medline] |
| 18. | Creagh, E. M., and L. A. O'Neill. 2006. TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol. 27:352-357.[CrossRef][Medline] |
| 19. | Dinarello, C. A. 1998. Interleukin-1B, interleukin-18, and the interleukin-1B converting enzyme. Ann. N. Y. Acad. Sci. 856:1-11. |
| 20. | Eggers, C. H., M. J. Caimano, M. L. Clawson, W. G. Miller, D. S. Samuels, and J. D. Radolf. 2002. Identification of loci critical for replication and compatibility of a Borrelia burgdorferi cp32 plasmid and use of a cp32-based shuttle vector for the expression of fluorescent reporters in the Lyme disease spirochaete. Mol. Microbiol. 43:281-295.[CrossRef][Medline] |
| 21. | Eggers, C. H., M. J. Caimano, and J. D. Radolf. 2006. Sigma factor selectivity in Borrelia burgdorferi: RpoS recognition of the ospE/ospF/elp promoters is dependent on the sequence of the 10 region. Mol. Microbiol. 59:1859-1875.[CrossRef][Medline] |
| 22. | Fanger, N. A., D. Voigtlaender, C. Liu, S. Swink, K. Wardwell, J. Fisher, R. F. Graziano, L. C. Pfefferkorn, and P. M. Guyre. 1997. Characterization of expression, cytokine regulation, and effector function of the high affinity IgG receptor Fc gamma RI (CD64) expressed on human blood dendritic cells. J. Immunol. 158:3090-3098.[Abstract] |
| 23. | Fonteneau, J. F., M. Larsson, A. S. Beignon, K. McKenna, I. Dasilva, A. Amara, Y. J. Liu, J. D. Lifson, D. R. Littman, and N. Bhardwaj. 2004. Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells. J. Virol. 78:5223-5232. |
| 24. | Franchi, L., A. Amer, M. Body-Malapel, T. D. Kanneganti, N. Ozoren, R. Jagirdar, N. Inohara, P. Vandenabeele, J. Bertin, A. Coyle, E. P. Grant, and G. Nunez. 2006. Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1B in Salmonella-infected macrophages. Nat. Immunol. 7:576-582.[CrossRef][Medline] |
| 25. | Fraser, C. M., S. Casjens, W. M. Huang, G. G. Sutton, R. Clayton, R. Lathigra, O. White, K. A. Ketchum, R. Dodson, E. K. Hickey, M. Gwinn, B. Dougherty, J. F. Tomb, R. D. Fleischmann, D. Richardson, J. Peterson, A. R. Kerlavage, J. Quackenbush, S. Salzberg, M. Hanson, R. van Vugt, N. Palmer, M. D. Adams, J. Gocayne, J. Weidman, T. Utterback, L. Watthey, L. McDonald, P. Artiach, C. Bowman, S. Garland, C. Fujii, M. D. Cotton, K. Horst, K. Roberts, B. Hatch, H. O. Smith, and J. C. Venter. 1997. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 390:580-586.[CrossRef][Medline] |
| 26. | Fraser, C. M., S. J. Norris, G. M. Weinstock, O. White, G. G. Sutton, R. Dodson, M. Gwinn, E. K. Hickey, R. Clayton, K. A. Ketchum, E. Sodergren, J. M. Hardham, M. P. McLeod, S. Salzberg, J. Peterson, H. Khalak, D. Richardson, J. K. Howell, M. Chidambaram, T. Utterback, L. McDonald, P. Artiach, C. Bowman, M. D. Cotton, and J. C. Venter. 1998. Complete genome sequence of Treponema pallidum, the syphilis spirochete. Science 281:375-388. |
| 27. | Fujii, S., K. Shimizu, M. Kronenberg, and R. M. Steinman. 2002. Prolonged IFN- -producing NKT response induced with alpha-galactosylceramide-loaded DCs. Nat. Immunol. 3:867-874.[CrossRef][Medline] |
| 28. | Gavrilin, M. A., I. J. Bouakl, N. L. Knatz, M. D. Duncan, M. W. Hall, J. S. Gunn, and M. D. Wewers. 2006. Internalization and phagosome escape required for Francisella to induce human monocyte IL-1ß processing and release. Proc. Natl. Acad. Sci. USA 103:141-146. |
| 29. | Gerosa, F., B. Baldani-Guerra, C. Nisii, V. Marchesini, G. Carra, and G. Trinchieri. 2002. Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 195:327-333. |
| 30. | Glickstein, L., M. Edelstein, and J. Z. Dong. 2001. Gamma interferon is not required for arthritis resistance in the murine Lyme disease model. Infect. Immun. 69:3737-3743. |
| 31. | Grazia, C. M., F. S. Sutterwala, G. Trinchieri, D. M. Mosser, and X. Ma. 2001. Suppression of IL-12 transcription in macrophages following Fc receptor ligation. J. Immunol. 166:4498-4506. |
| 32. | Hazlett, K. R. O., T. J. Sellati, T. T. Nguyen, D. L. Cox, M. L. Clawson, M. J. Caimano, and J. D. Radolf. 2001. The T. pallidumrK protein of Treponema pallidum is periplasmic and is not a target of opsonic antibody or protective immunity. J. Exp. Med. 193:1015-1026. |
| 33. | Hengge, U. R., A. Tannapfel, S. K. Tyring, R. Erbel, G. Arendt, and T. Ruzicka. 2003. Lyme borreliosis. Lancet Infect. Dis. 3:489-500.[CrossRef][Medline] |
| 34. | Hilbi, H., J. E. Moss, D. Hersh, Y. Chen, J. Arondel, S. Banerjee, R. A. Flavell, J. Yuan, P. J. Sansonetti, and A. Zychlinsky. 1998. Shigella-induced apoptosis is dependent on caspase-1 which binds to IpaB. J. Biol. Chem. 273:32895-32900. |
| 35. | Hirschfeld, M., C. J. Kirschning, R. Schwandner, H. Wesche, J. H. Weis, R. M. Wooten, and J. J. Weis. 1999. Inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by Toll-like receptor 2. J. Immunol. 163:2382-2386. |
| 36. | Hirschfeld, M., Y. Ma, J. H. Weis, S. N. Vogel, and J. J. Weis. 2000. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J. Immunol. 165:618-622. |
| 37. | Imlach, S., C. Leen, J. E. Bell, and P. Simmonds. 2003. Phenotypic analysis of peripheral blood ![]() T lymphocytes and their targeting by human immunodeficiency virus type 1 in vivo. Virology 305:415-427.[CrossRef][Medline] |
| 38. | Kadowaki, N., S. Ho, S. Antonenko, M. R. de Waal, R. A. Kastelein, F. Bazan, and Y. J. Liu. 2001. Subsets of human dendritic cell precursors express different Toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194:863-870. |
| 39. | Kang, I., S. W. Barthold, D. H. Persing, and L. K. Bockenstedt. 1997. T-helper-cell cytokines in the early evolution of murine Lyme arthritis. Infect. Immun. 65:3107-3111.[Abstract] |
| 40. | Kronenberg, M., and L. Gapin. 2002. The unconventional lifestyle of NKT cells. Nat. Rev. Immunol. 2:557-568.[Medline] |
| 41. | Latz, E., A. Schoenemeyer, A. Visintin, K. A. Fitzgerald, B. G. Monks, C. F. Knetter, E. Lien, N. J. Nilsen, T. Espevik, and D. T. Golenbock. 2004. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat. Immunol. 5:190-198.[CrossRef][Medline] |
| 42. | Liu, Y., E. Masuda, M. C. Blank, K. A. Kirou, X. Gao, M. S. Park, and L. Pricop. 2005. Cytokine-mediated regulation of activating and inhibitory Fc receptors in human monocytes. J. Leukoc. Biol. 77:767-776. |
| 43. | Lukehart, S. A. 1992. Immunology and pathogenesis of syphilis, p. 141-163. In T. C. Quinn (ed.), Advances in host defense mechanisms, vol. 8. Sexually transmitted diseases. Raven Press, New York, NY. |
| 44. | Lukehart, S. A. 2004. Syphilis, p. 977-985. In E. Brauwald, A. S. Faucci, S. L. Hauser, D. L. Longo, and J. L. Jameson (ed.), Harrison's principles of internal medicine. McGraw Hill, New York, NY. |
| 45. | Lukehart, S. A., and J. N. Miller. 1978. Demonstration of the in vitro phagocytosis of Treponema pallidum by rabbit peritoneal macrophages. J. Immunol. 121:2014-2024. |
| 46. | Ma, X., J. M. Chow, G. Gri, G. Carra, F. Gerosa, S. F. Wolf, R. Dzialo, and G. Trinchieri. 1996. The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J. Exp. Med. 183:147-157. |
| 47. | Ma, Y., and J. J. Weis. 1993. Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties. Infect. Immun. 61:3843-3853. |
| 48. | Marshall, J. D., D. S. Heeke, C. Abbate, P. Yee, and N. G. Van. 2006. Induction of interferon- from natural killer cells by immunostimulatory CpG DNA is mediated through plasmacytoid-dendritic-cell-produced interferon- and tumour necrosis factor- . Immunology 117:38-46.[CrossRef][Medline] |
| 49. | Martin-Fontecha, A., L. L. Thomsen, S. Brett, C. Gerard, M. Lipp, A. Lanzavecchia, and F. Sallusto. 2004. Induced recruitment of NK cells to lymph nodes provides IFN- for T(H)1 priming. Nat. Immunol. 5:1260-1265.[CrossRef][Medline] |
| 50. | Martinon, F., K. Burns, and J. Tschopp. 2002. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-1B. Mol. Cell 10:417-426.[CrossRef][Medline] |
| 51. | Matsuzaki, G., H. Yamada, K. Kishihara, Y. Yoshikai, and K. Nomoto. 2002. Mechanism of murine V 1+ ![]() T cell-mediated innate immune response against Listeria monocytogenes infection. Eur. J. Immunol. 32:928-935.[CrossRef][Medline] |
| 52. | Matyniak, J. E., and S. L. Reiner. 1995. T helper phenotype and genetic susceptibility in experimental Lyme disease. J. Exp. Med. 181:1251-1254. |
| 53. | Molofsky, A. B., B. G. Byrne, N. N. Whitfield, C. A. Madigan, E. T. Fuse, K. Tateda, and M. S. Swanson. 2006. Cytosolic recognition of flagellin by mouse macrophages restricts Legionella pneumophila infection. J. Exp. Med. 203:1093-1104. |